Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD-1 antibody, chidamide, lenalidomide, and gemcitabine for PTCL
NCT04040491Phase 4Unknown
- Start
- Sep 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tucidinostat, lenalidomide, gemcitabine in peripheral T-cell lymphoma (PTCL). Status: unknown.
02
Drugs
tucidinostatlenalidomidegemcitabine
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT04040491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04040491.